Contact PR

To use this feature, join Babbler easily !

arrow_back

Babbler allows PR people and reporters to collaborate a better way.

By joining Babbler you will be able to access hundreds of newsrooms and PR contacts from your industrie(s) and also share with them your upcoming needs.

Their newsrooms are already on Babbler

You're 1 click away from signing up

Previous

Nice to see you again !

Press release

First head-to-head Randomized Controlled Trial shows reduced low blood sugar
timer minutes reading time minute reading time

Copy link
first-head-to-head-randomized-controlled-trial-shows-reduced-low-blood-sugar

Click to get original image size

Sanofi presents results from the first head-to-head study comparing Toujeo® to insulin degludec

 

First head-to-head Randomized Controlled Trial shows reduced low blood sugar events in patients new to basal insulin treatment in the first 12 weeks

 

June 25, 2018


Background: Importance of the titration period for patients new to basal insulins

 

While long-acting insulin is the cornerstone of treatment for millions of people with diabetes around the world, its use also comes with the challenge of low blood sugar events (hypoglycemia).

  • Health & Medicine
  • Medicine
inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here

  • Health & Medicine
  • Medicine